Table 1 Baseline sociodemographic characteristics (N = 382)

From: Comparative effectiveness of remote perioperative telemonitoring in cancer surgery: a randomized trial

Characteristics

Overall

(N = 382)

Surgeon only perioperative care (n = 193)

Remote perioperative telemonitoring care (n = 189)

P-value

Gender

   

0.60

Male

199 (52.1%)

98 (50.8%)

101 (53.4%)

 

Female

183 (47.9%)

95 (49.2%)

88 (46.6%)

 

Age, years

60.6 (11.4)

60.9 (11.2)

60.3 (11.7)

0.67

Ethnicity

   

0.49

Non-Hispanic

245 (65.3%)

128 (67.0%)

117 (63.6%)

 

Hispanic

130 (34.7%)

63 (33.0%)

67 (36.4%)

 

(Not reported)

7

2

5

 

Race

   

0.63

White

279 (76.2%)

148 (77.9%)

131 (74.4%)

 

Asian

30 (8.2%)

16 (8.4%)

14 (8.0%)

 

African American

15 (4.1%)

7 (3.7%)

8 (4.5%)

 

Native Hawaiian/other Pacific Islander

3 (0.8%)

2 (1.1%)

1 (0.6%)

 

American Indian/Alaska Native

2 (0.5%)

2 (1.1%)

0 (0.0%)

 

More than one race

7 (1.9%)

2 (1.1%)

5 (2.8%)

 

Other

30 (8.2%)

13 (6.8%)

17 (9.7%)

 

(Not reported)

16

3

13

 

Education

   

0.50

High school or less

74 (20.0%)

35 (18.9%)

39 (21.1%)

 

College/Vocational School

215 (58.1%)

113 (61.1%)

102 (55.1%)

 

Graduate school

81 (21.9%)

37 (20.0%)

44 (23.8%)

 

(Not reported)

12

8

4

 

Relationship status

   

>0.9

Single

61 (16.1%)

30 (15.6%)

31 (16.5%)

 

Married/partnered

257 (67.6%)

132 (68.8%)

125 (66.5%)

 

Separated/divorced/widowed

60 (15.8%)

29 (15.1%)

31 (16.5%)

 

Other

2 (0.6%)

1 (0.6%)

1 (0.6%)

 

(Not reported)

2

1

1

 

Who lives with patients

   

>0.9

Live alone

39 (10.3%)

20 (10.5%)

19 (10.1%)

 

Live with family/friend/significant other

340 (89.7%)

171 (89.5%)

169 (89.9%)

 

(Not reported)

3

2

1

 

Primary language

   

0.38

English

339 (89%)

174 (90%)

165 (87%)

 

Spanish

43 (11%)

19 (9.8%)

24 (13%)

 

Diagnosis,n=382

   

0.84

Gastrointestinal (GI)

134 (35.1%)

65 (33.7%)

69 (36.5%)

 

Genitourinary (GU)

137 (35.9%)

71 (36.8%)

66 (34.9%)

 

Gynecologic (GYN)

111 (29.1%)

57 (29.5%)

54 (28.6%)

 

Neoadjuvant treatments

Preoperative chemotherapy

95 (24.9%)

52 (26.9%)

43 (22.8%)

0.3

Preoperative radiation therapy

20 (5.2%)

10 (5.2%)

10 (5.3%)

0.8

Type of procedure,n=366

   

<0.001

Prostatectomy

84 (23.0%)

41 (22.5%)

43 (23.4%)

 

Hysterectomy

60 (16.4%)

23 (12.6%)

37 (20.1%)

 

Colectomy

28 (7.7%)

22 (12%)

6 (3.3%)

 

Cystectomy

16 (4.4%)

15 (8.2%)

1 (0.5%)

 

Hepatectomy

12 (3.3%)

7 (3.8%)

5 (2.7%)

 

Nephrectomy

11 (3.0%)

3 (1.6%)

8 (4.3%)

 

Gastrectomy

7 (1.9%)

4 (2.2%)

3 (1.6%)

 

Pancreatectomy/Whipple

7 (1.9%)

6 (3.3%)

1 (0.5%)

 

Esophagectomy

5 (1.4%)

2 (1.1%)

3 (1.6%)

 

Low anterior resection

4 (1.1%)

3 (1.6%)

1 (0.5%)

 

Salpingo-oopherectomy

4 (1.1%)

3 (1.6%)

1 (0.5%)

 

Abdominoperitoneal resection

3 (0.8%)

0 (0%)

3 (1.6%)

 

Esophagogastrectomy

2 (0.5%)

0 (0%)

2 (1.1%)

 

Other

123 (33.6%)

53 (29.1%)

70 (38%)

 

Not applicable due to no surgery (n)

16

11

5

 

Surgical approach,n=366

Minimally invasive

(Robotic or Lap)

271 (74%)

140 (77%)

131 (71%)

0.2

Open

95 (26%)

42 (23.1%)

53 (28.8%)

0.2

Postoperative events,n=366

   

0.4

Yes

113 (31%)

60 (33%)

53 (29%)

 

No

253 (69%)

122 (67%)

131 (71%)